Liraglutide (Saxenda)

Liraglutide, marketed as Saxenda for weight management, is a GLP-1 receptor agonist that helps patients achieve an average 8-10% body weight loss. While less potent than semaglutide, liraglutide has a longer clinical track record and may be preferred for patients who are new to GLP-1 therapy or want a more gradual approach.

Administered as a daily subcutaneous injection, liraglutide reduces appetite, slows gastric emptying, and improves metabolic markers. At hi-doctor.ai, our doctors help determine whether liraglutide or semaglutide is the best starting point based on your health profile and weight loss goals.

Like semaglutide, liraglutide mimics the GLP-1 hormone, but with a shorter duration requiring daily dosing. It reduces appetite, promotes satiety, and improves insulin sensitivity.

Similar to semaglutide: nausea, diarrhea, constipation. Usually mild and improving with continued use. Gradual dose titration reduces side effects.